Live news related to MEDINCELL stock (FR0004065605): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
MedInCell's stock saw a significant increase this Wednesday at midday, posting a gain of 5.46% to 22.02 euros. This rebound occurs in a context of gen…
MedInCell's stock saw a sharp increase this Monday at midday, climbing 6.13% to 21.48 euros, amid a strong rebound in the Paris market. The Montpellie…
MedInCell shares fell 2.48% at the opening of the session this Thursday, March 19, trading at 20.46 euros in a declining Parisian market. The CAC 40 i…
MedInCell shares fell 2.38% this Tuesday midday to €20.48, in a Parisian market that is otherwise on the rise, with the CAC 40 up by 0.59% during the …
MedInCell's stock price significantly advanced this Monday during trading, reaching 20.84 euros compared to 20.34 euros at last Friday's close. This 2…
MedInCell shares experience a significant drop this Thursday, losing 4.35% to 21.10 euros during the session, in a Parisian market that is also trendi…
MedInCell's stock experienced a significant drop this Wednesday, falling 3.95% to 21.88 euros during the session. The Montpellier-based biotech is ope…
MedInCell's stock has risen by 2.29% at midday this Tuesday, March 10, trading at 22.32 euros after closing at 21.82 euros the previous day. This tech…
Biotech company Medincell has completed a private placement of 48 million euros aimed at strengthening its technology platform for long-acting injecta…
Medincell, a biopharmaceutical laboratory specializing in long-acting injectable treatments, announces its participation in the Leerink Global Healthc…
